UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) Registrant's Telephone Number, ...

cbdMD, Inc. (NYSE:YCBD) Q1 2021 Earnings Conference Call February 9, 2021 4:15 PM ET Company Representatives Marty Sumichrast - Chairman, Co-CEO Ronan Kennedy - Chief Financial Officer Ken Cohn - Chief Marketing Officer Conference Call Participants Scott Fortune - Roth Capital Partners Operator Good afternoon. Welcome to the cbdMD Inc. December 31, 2020, First Quarter Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its first quarter fiscal 2021 resul ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-38299 cbdMD, INC. (Exact name of registrant as specified in its charter) North Carolina 47-3414576 (S ...

cbdMD, Inc. (NYSE:YCBD) Q4 2020 Earnings Conference Call December 22, 2020 4:15 PM ET Company Participants Ronan Kennedy - CFO Marty Sumichrast - Chairman and Co-CEO Ken Cohn - Chief Marketing Officer Conference Call Participants Paul Cooney - Joseph Gunnar Michael Galantino - Chapin Davis Barry Mendel - Mendel Money Management Operator Good afternoon. Welcome to the cbdMD Incorporated Fourth Quarter and Fiscal Year Ended September 30, 2020 Earnings Call and Update. This afternoon, the company issued a pres ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-38299 CBDMD, INC. (Exact name of registrant as specified in its charter) North Carolina 47-3414576 (State ...

cbdMD, Inc. (NYSE:YCBD) Q3 2020 Results Earnings Conference Call August 12, 2020 4:15 PM ET Company Participants Mark Elliott - CFO and COO Marty Sumichrast - Chairman and Co CEO Ken Cohn - Chief Marketing Officer Lance Blundell - General Counsel Conference Call Participants Paul Cooney - Joseph Gunnar Aaron Grey - Alliance Global Partners Scott Fortune - Roth Capital Partners Gerald Pascarelli - Cowen Operator Good afternoon. And welcome to the cbdMD Third Quarter Fiscal 2020 Earnings Call and Update. Th ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North Carolina 47-3414576 State ...

cbdMD, Inc. (NYSE:YCBD) Q2 2020 Earnings Conference Call May 18, 2020 1:45 PM ET Company Participants Marty Sumichrast - Chairman and Co CEO Mark Elliott - CFO and COO Conference Call Participants Scott Fortune - Roth Capital Partners Paul Cooney - Joseph Gunnar Michael Lavery - Piper Sandler Pablo Zuanic - Cantor Fitzgerald Bill Sutherland - Benchmark Paul Bornstein - Black Diamond Daby Carreras - Spartan Capital Steve Emerson - Emerson Investments Operator Good afternoon. And welcome to the cbdMD Secon ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-38299 cbdMD, INC. (Exact Name of Registrant as Specified in its Charter) North Carolina 47-3414576 State ...

cbdMD, Inc. (NYSE:YCBD) Q1 2020 Earnings Conference Call February 13, 2020 4:15 PM ET Company Participants Mark Elliott – Chief Financial Officer Marty Sumichrast – Chairman and Co-Chief Executive Officer Conference Call Participants Bill Sutherland – Benchmark Scott Rothbaum – Joseph Gunnar Barry Rubin – Private Investor Operator Good afternoon. Welcome to the cbdMD First Quarter Fiscal 2020 Earnings Call and Update. This afternoon, the company issued a press release that provided an overview of its first ...